Jingrong Jean Cui, Chief Scientific Officer at Turning Point Therapeutics, Inc. (TPTX), sold 41,500 shares at $55.43 ($2.4M) on 2019-12-13, disclosed to the SEC on 2019-12-17.
Open-market sale of $2.4M TPTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.43 | 7,100 | $394K | 16.1% |
| 2 | $56.17 | 3,800 | $213K | 8.7% |
| 3 | $56.95 | 600 | $34K | 1.4% |
| 4 | $55.45 | 600 | $33K | 1.4% |
| 5 | $56.84 | 2,000 | $114K | 4.6% |
| 6 | $57.59 | 1,300 |
| $75K |
| 3.1% |
| 7 | $58.75 | 5,000 | $294K | 12.0% |
| 8 | $59.76 | 2,400 | $143K | 5.9% |
| 9 | $60.43 | 200 | $12K | 0.5% |
| 10 | $60.30 | 3,600 | $217K | 8.9% |
| 11 | $61.13 | 8,100 | $495K | 20.2% |
| 12 | $62.05 | 6,495 | $403K | 16.5% |
| 13 | $62.71 | 305 | $19K | 0.8% |
| Total | $58.95 avg | 41,500 | $2.4M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |